Result of AGM

GlaxoSmithKline PLC
25 May 2005

Issued - Wednesday 25th May 2005, London - LSE Announcement


                     GlaxoSmithKline plc - Results of AGM


GlaxoSmithKline (GSK) announces that at today's Annual General Meeting all
resolutions, including those electing and re-electing Board members, were passed
by shareholders.


              GlaxoSmithKline Annual General Meeting Poll Results


The following table shows the votes cast for each resolution:


          Resolution           Total votes for     %      Total votes    %      Total votes   Abstentions**
                                      *                     against                cast
 01  Adoption of Financial       3,906,841,624    98.79%    47,758,594  1.21%   3,954,600,218   175,150,362
     Statements
 02  Approval of the             3,800,433,274    95.40%   183,067,146  4.60%   3,983,500,420   146,250,160
     Remuneration
     Report
 03  Election of Sir             4,099,468,431    99.62%    15,431,801  0.38%   4,114,900,232    14,850,348
     Christopher Gent
 04  Election of Sir Deryck      4,104,142,353    99.75%    10,428,930  0.25%   4,114,571,283    15,179,297
     Maughan
 05  Election of Mr J Heslop     4,100,614,116    99.66%    14,129,375  0.34%   4,114,743,491    15,007,089
 06  Re-election of Dr J-P       4,099,153,866    99.61%    15,882,823  0.39%   4,115,036,689    14,713,891
     Garnier
 07  Re-election of Sir Ian      4,103,392,185    99.73%    11,267,847  0.27%   4,114,660,032    15,090,548
     Prosser
 08  Re-election of Dr R         4,103,662,925    99.74%    10,802,992  0.26%   4,114,465,917    15,284,663
     Schmitz
 09  Re-election of Dr L         4,096,777,184    99.57%    17,647,353  0.43%   4,114,424,537    15,326,043
     Shapiro
 10  Re-appointment of           4,055,015,241    99.48%    21,364,410  0.52%   4,076,379,651    53,370,929
     Auditors
 11  Remuneration of Auditors    4,098,763,019    99.62%    15,675,183  0.38%   4,114,438,202    15,312,378
 12  Autrhorise donations to     4,024,458,274    98.08%    78,854,300  1.92%   4,103,312,574    26,438,006
     EU Political
     Organisations & incur EU
     Political
     Expenditure
 13  Disapplication of           4,067,878,763    99.05%    39,147,397  0.95%   4,107,026,160    22,724,420
     pre-emption
     rights***
 14  Authority for the Company   4,106,321,241    99.80%     8,129,177  0.20%   4,114,450,418    15,300,162
     to
     purchase its own shares***
 15  Insertion of new Articles   4,088,185,649    99.84%     6,721,259  0.16%   4,094,906,908    34,843,672
     48A into
     the Articles of
     Association***
 16  Deletion of Article 154.2   4,087,140,974    99.79%     8,426,154  0.21%   4,095,567,128    34,183,452
     of the
     Articles of Association***
 17  Amendment to Article 81     4,090,361,524    99.88%     5,032,818  0.12%   4,095,394,342    34,356,238
     of the
     Articles of Association***





Notes:

*    Includes discretionary votes.

**   An abstention is not a vote in law and is not counted in the
     calculation of the proportion of votes "For" or "Against" a resolution.

***  Indicates Special Resolutions requiring a 75% majority



The following table provides further relevant information:




                                                        GlaxoSmithKline's         GlaxoSmithKline's
                                                        Fifth AGM (2005)          Fourth AGM (2004)


Issued share capital                                             5,852,415,354            5,921,564,431

(excluding Treasury Shares)


Total votes cast and abstentions lodged as a % of                       70.56%                   66.75%
GSK's issued share capital (excluding Treasury
Shares).


Total shareholder population.                                          209,029                  230,939


Total number of proxies lodged.                                         16,156                   17,400


% of shareholders who lodged proxies.                                    7.73%                    7.53%


Number of shareholders,  corporate representatives                         286                      349
and proxies who attended the AGM





S M Bicknell
Company Secretary
25th May 2005



These results will shortly be available on the Company's website www.gsk.com.



Enquiries:

UK Media enquiries:                                    Philip Thomson          [phone]
                                                       David Mawdsley          [phone]
                                                       Chris Hunter-Ward       [phone]
                                                       Alice Hunt              [phone]

US Media enquiries:                                    Nancy Pekarek           [phone]
                                                       Mary Anne Rhyne         [phone]
                                                       Patricia Seif           (215)  751 7709

European Analyst/Investor enquiries:                   Duncan Learmouth        [phone]
                                                       Anita Kidgell           [phone]
                                                       Jen Hill                [phone]

US Analyst/ Investor enquiries:                        Frank Murdolo           [phone]
                                                       Tom Curry               [phone]



                      This information is provided by RNS
            The company news service from the London Stock Exchange